PARC is the new European partnership for the risk assessment of PFAS and other endocrine disruptors, launched in 2022. Some two hundred national and European health and environmental agencies and research organizations are working together to promote research, share knowledge and improve chemical risk assessment. In doing so, they contribute to a well-founded EU strategy for sustainable chemicals and help pave the way to zero pollution. The partnership builds on the European program on human biomonitoring that is coming to an end, but also looks at environmental risks.
Read more about
PARC
